Raras
Buscar doenças, sintomas, genes...
Líquen amiloidótico
ORPHA:49804CID-10 · E85.4+CID-11 · 5D00.0DOENÇA RARA

A amiloidose liquenoide é uma doença rara e crônica da pele, marcada pelo acúmulo de depósitos de uma substância chamada amiloide na derme (uma das camadas da pele). Os sintomas visíveis (clínicos) incluem o surgimento de pequenas lesões na pele, tipo bolinhas ou caroços, que coçam muito. Essas lesões, que costumam ser mais escuras e ter a pele mais grossa ou áspera, aparecem no tronco e nos membros (braços e pernas), principalmente nas canelas. E, ao exame microscópico de uma amostra de pele (biópsia), observa-se o depósito de proteínas do tipo amiloide na camada mais superficial da derme.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A amiloidose liquenoide é uma doença rara e crônica da pele, marcada pelo acúmulo de depósitos de uma substância chamada amiloide na derme (uma das camadas da pele). Os sintomas visíveis (clínicos) incluem o surgimento de pequenas lesões na pele, tipo bolinhas ou caroços, que coçam muito. Essas lesões, que costumam ser mais escuras e ter a pele mais grossa ou áspera, aparecem no tronco e nos membros (braços e pernas), principalmente nas canelas. E, ao exame microscópico de uma amostra de pele (biópsia), observa-se o depósito de proteínas do tipo amiloide na camada mais superficial da derme.

Publicações científicas
246 artigos
Último publicado: 2026 Apr 10
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E85.4+
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Características mais comuns

90%prev.
Prurido
Muito frequente (99-80%)
90%prev.
Pápula
Muito frequente (99-80%)
2sintomas
Muito frequente (2)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 2 características clínicas mais associadas, ordenadas por frequência.

PruridoPruritus
Muito frequente (99-80%)90%
PápulaPapule
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico246PubMed
Últimos 10 anos104publicações
Pico202519 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico2
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 2 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Líquen amiloidótico

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

5 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
106 papers (10 anos)
#1

Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.

International journal of dermatology2026 Mar

Endocrine tumor syndromes, including multiple endocrine neoplasia types 1, 2A, and 2B (MEN1, MEN2A, MEN2B), Carney complex (CNC), and PTEN hamartoma tumor syndrome (PHTS), are hereditary conditions characterized by multisystem tumor development. Alongside endocrine neoplasms, these syndromes present with diverse cutaneous manifestations, offering valuable diagnostic clues for early recognition and management. This systematic review and meta-analysis aimed to evaluate and synthesize the dermatologic features associated with these syndromes. Following PRISMA 2020 guidelines, a systematic search of MEDLINE, Cochrane Library, and Embase databases was conducted. Eligible publications included original articles, case reports, and case series with detailed dermatological descriptions of patients with the aforementioned syndromes. Data extraction and risk of bias assessment were performed independently by multiple reviewers. Statistical analyses and data visualization were conducted using program package R. A total of 217 studies comprising 833 patients were included: 276 MEN1, 48 MEN2A, 9 MEN2B, 121 CNC, and 452 PHTS cases. Distinct dermatologic patterns emerged within each syndrome: angiofibromas, collagenomas, and lipomas in MEN1; cutaneous lichen amyloidosis in MEN2A; mucosal neuromas in MEN2B; lentiginosis and cutaneous myxomas in CNC; and trichilemmomas, papillomatous papules, and acral keratoses in PHTS. Melanoma prevalence was 2.2% in PHTS and 2.5% in MEN1 patients, underscoring the need for dermatologic vigilance. This review highlights the role of dermatologic assessment in identifying endocrine tumor syndromes, with cutaneous findings often serving as early, accessible markers of systemic disease. Enhanced awareness of these manifestations can facilitate timely genetic evaluation, cancer surveillance, and multidisciplinary intervention. Trial Registration: PROSPERO registration number: CRD42024558093.

#2

Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.

PloS one2025

To investigate the genotype-phenotype correlations of multiple endocrine neoplasia type 2A (MEN2A) caused by mutations in exon 10 of the RET gene in Ethnic Han Chinese. A retrospective analysis was conducted on the family history and genetic characteristics of 14 independent MEN2A pedigrees, all carrying exon 10 mutations of the RET gene, from July 2003 to August 2023. A total of 74 out of 133 participants carried germline mutations in exon 10 of the RET gene. The cohort included 26 males and 48 females, with nine types of mutations observed: p.C609R, p.C611F/Y, p.C618G/R/S/Y and p.C620R/S. Of these, the C618 mutation was the most prevalent (71.6%), followed by p.C611 (22.9%), p.C620 (4.1%), and p.C609 (1.4%). The penetrance rates for medullary thyroid carcinoma (MTC), pheochromocytoma, hyperparathyroidism, hirschsprung disease, and cutaneous lichen amyloidosis were 90.3%, 6.9%, 2.8%, 1.4% and 1.4%, respectively. Among the 72 patients with available clinical information, 41 (56.9%) exhibited symptoms of MTC. Comparison of the age at diagnosis, size of MTC, and the positive rate of cervical lymph node metastasis (N1) revealed significant differences between patients with symptomatic and asymptomatic MTC (all P < 0.05). There was a significant difference in the positivity rate of N1 between patients with the p.C618/C620 mutations and those with the p.C609/C611 mutations. Additionally, there was a significant difference in the initial serum calcitonin levels between N1 and N0 patients (P < 0.05). Exon 10 mutations of the RET gene are frequently located in codon 618 and contribute to the familial MTC phenotype. To improve the recognition of MEN2A, integrating family history, testing for RET mutations, and monitoring serum calcitonin levels are essential for early diagnosis and personalised treatment.

#3

An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.

Nature communications2025 Jun 02

Atopic dermatitis (AD) is a skin disease exhibiting clinical and molecular heterogeneity, thereby jeopardizing the development of personalized treatments. Here we pursue a cross-sectional and longitudinal cohort analysis of 951 whole-skin samples, employing an unsupervised decomposition analysis to link gene expression profiles to disease severity, six distinct skin phenotypes, and blood cytokines representative of given endotypes. Specifically, type 2 and type 17 responses are associated with major skin phenotypes such as erythema and induration, while type 1 response is upregulated in lichen amyloidosis of AD patients. Longitudinal analysis of patients treated with dupilumab finds sustained gene signatures related to type 17 response in lesional skin and upregulated transcription factors in non-lesional skin of patients with poor treatment outcomes. Lastly, several extracellular matrix organization-associated genes are correlated with clinical severity and treatment response to dupilumab. Our findings thus provide potential skin and blood biomarkers for assessing endotypes and therapeutic responses in AD to pave the way for personalized medicine.

#4

Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib.

The Kaohsiung journal of medical sciences2025 Nov 29
#5

Landscape of Phenotype-Genotype Correlations in Romanian Patients with Medullary Thyroid Carcinoma.

Cancers2025 Dec 27

To comprehensively characterize the genetic landscape of medullary thyroid carcinoma (MTC) in a Romanian cohort. Germline and somatic RET testing were performed in 164 MTC patients (105 sporadic, 59 hereditary) consecutively enrolled at a single tertiary center (2021-2024) using genomic DNA or DNA extracted from fresh surgical or paraffin-embedded pathology specimens. Hereditary MTC (hMTC) accounted for 59/164 (35.9%) cases. Among hMTC, 58/59 (98.3%) had MEN2 (72.4% classic, 5.2% with cutaneous lichen amyloidosis, 5.2% with Hirschsprung disease, and 17.2% with familial medullary thyroid carcinoma), and 1/59 (1.7%) had MEN3. Codon 634 mutations were the most prevalent (33/59, 55.9%). Extracellular cysteine-rich domain mutations were significantly more prevalent in syndromic cases (p = 0.006), while non-cysteine mutations were predominant in apparently sporadic cases (p = 0.006). In advanced MTC (stage III/IV or metastatic), the somatic M918T mutation was the most common (15/20, 75% cases). Germline RET screening is mandatory for all MTC cases. Somatic testing is critical in advanced disease, where M918T prevails in 75% of cases and guides tyrosine kinase inhibitor therapy. Codon 634 is the most frequent mutation in Romanian MTC, highlighting regional variation warranting population-adjusted screening and earlier prophylactic thyroidectomy.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC163 artigos no totalmostrando 103

2025

Landscape of Phenotype-Genotype Correlations in Romanian Patients with Medullary Thyroid Carcinoma.

Cancers
2025

Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib.

The Kaohsiung journal of medical sciences
2025

Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports.

Clinical, cosmetic and investigational dermatology
2026

Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.

International journal of dermatology
2025

Remission of lichen amyloidosis achieved with upadacitinib: A case report.

JAAD case reports
2025

Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.

PloS one
2025

Treatment of primary cutaneous amyloidosis with tofacitinib: preliminary observations from a single-arm clinical trial.

Clinical and experimental dermatology
2025

Nemolizumab for treatment of lichen amyloidosis.

JAAD case reports
2025

Lichen Amyloidosis of Legs Treated with Topical Corticosteroids and NB-UVB Phototherapy.

Indian dermatology online journal
2025

Nemolizumab for the treatment of refractory primary localized cutaneous amyloidosis in a nonatopic patient.

JAAD case reports
2025

An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.

Nature communications
2025

Effective dupilumab treatment for lichen amyloidosis with GATA3+ cell infiltration.

European journal of dermatology : EJD
2025

Successful treatment of lichen amyloidosis with cryotherapy.

Indian journal of dermatology, venereology and leprology
2025

Generalized lichen amyloidosis in a pregnant woman: Coincidence or association.

Obstetric medicine
2025

Analysing the Role of Ultraviolet A1 Phototherapy in the Treatment of Primary Cutaneous Lichen Amyloidosis in a Patient With Skin Phototype 1.

Photodermatology, photoimmunology &amp; photomedicine
2025

Histopathological Insights into Primary Localized Cutaneous Amyloidosis: A Case Series.

Cureus
2025

Rapid clinical response to nemolizumab in dermatologic diseases associated with pruritus and burning: A multicenter case series.

Journal of the American Academy of Dermatology
2025

Hereditary Medullary Thyroid Cancer: Genotype-Phenotype Correlation.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
2025

RET C611Y Germline Variant in Multiple Endocrine Neoplasia Type 2A in Denmark 1930-2021: A Nationwide Study.

Cancers
2024

Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis.

Frontiers in immunology
2024

Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2.

Clinics and practice
2024

A Case of Cushing's Disease and a RET Pathogenic Variant: Exploring Possible Rare Associations.

Cureus
2024

Use of dupilumab as a novel treatment for refractory lichen amyloidosis.

JAAD case reports
2024

Molecular diagnostic approaches in detecting rearranged during transfection oncogene mutations in multiple endocrine neoplasia type 2.

World journal of clinical cases
2025

Living with a RET gene mutation: patient perspectives.

Endocrine-related cancer
2024

Thyroid Malignancy and Cutaneous Lichen Amyloidosis: Key Points Amid RET Pathogenic Variants in Medullary Thyroid Cancer/Multiple Endocrine Neoplasia Type 2 (MEN2).

International journal of molecular sciences
2024

[Generalized Amyloid Lichen Associated with Primary Biliary Cholangitis: A Case Report].

Acta gastroenterologica Latinoamericana
2024

Lichen Amyloidosis of the External Ear.

Indian dermatology online journal
2024

Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option.

Diseases (Basel, Switzerland)
2023

Primary Localized Cutaneous Amyloidosis in Central Europe: A Retrospective Monocentric Study on Epidemiology and Therapy.

Journal of clinical medicine
2023

Clinical Characteristics of Lichen Amyloidosis Associated with Atopic Dermatitis: A Single Center, Retrospective Study.

Annals of dermatology
2024

The efficacy of topical 0.025% capsaicin gel for the treatment of lichen amyloidosis: A pilot study.

The Australasian journal of dermatology
2023

Improvement in Lesions of Co-Existing Lichen Amyloidosis and Vitiligo with Dexamethasone Oral Mini Pulse Therapy.

Indian dermatology online journal
2023

A Case Report of Generalized Non-pruritic Lichen Amyloidosis.

Cureus
2023

Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports.

World journal of clinical cases
2023

Immunoglobulin G4-Related Disease-Associated Dermatitis with Pruritus: A Positive Response to Dupilumab.

Life (Basel, Switzerland)
2023

Primary cutaneous amyloidosis: A review of the available studies and gaps in data.

The Australasian journal of dermatology
2022

Multiple skin neoplasms at one site (MUSK IN A NEST): collision tumor consisting of epidermal (macular seborrheic keratosis) and dermal (lichen amyloidosis) components.

Dermatology online journal
2023

Lichen amyloidosis: towards pathogenesis-driven targeted treatment.

Clinical and experimental dermatology
2022

Coexistent Lichen Amyloidosis and Acquired Reactive Perforating Collagenosis in Type 2 Diabetes Mellitus and Post-Thyroidectomy Hypothyroidism Due to Papillary Thyroid Carcinoma: A Rare Case.

International medical case reports journal
2023

Upadacitinib for treatment-resistant Lichen amyloidosis.

Journal of the European Academy of Dermatology and Venereology : JEADV
2022

High-Frequency Electrosurgery for Generalized Lichen Amyloidosis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2022

A unique case of concurrent cutaneous lichen amyloidosis and myxedema.

Dermatology online journal
2022

[Clinical and genetic analysis of seven Chinese pedigrees affected with multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2022

Refractory cutaneous lichen amyloidosis coexisting with atopic dermatitis responds to the Janus Kinase inhibitor baricitinib.

Dermatologic therapy
2022

A Case of Lichen Amyloidosis Successfully Treated with Alitretinoin.

Indian journal of dermatology
2022

Lichen Amyloidosis on the Scalp: A Case Report.

Clinical, cosmetic and investigational dermatology
2022

Anosacral amyloidosis in a Chinese-Caribbean male.

JAAD case reports
2021

Dermoscopic Features of Lichen Amyloidosis in Caucasians-A Case Series and Literature Review.

Medicina (Kaunas, Lithuania)
2022

The therapeutic role of lasers in primary localized cutaneous amyloidosis: a systematic review.

Lasers in medical science
2022

Primary Localized Cutaneous Amyloidosis: A Retrospective Study of an Uncommon Skin Disease in the Largest Tertiary Care Center in Switzerland.

Dermatology (Basel, Switzerland)
2021

Efficacy of 1064-nm Nd:YAG picosecond laser in lichen amyloidosis treatment: clinical and dermoscopic evaluation.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
2021

Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants.

American journal of clinical dermatology
2021

Elevated basal serum levels of calcitonin and simultaneous surgery of MEN2A-specific tumors.

Neoplasma
2021

FotoFinder Dermoscopy Analysis and Histopathological Correlation in Primary Localized Cutaneous Amyloidosis.

Dermatology practical &amp; conceptual
2021

A case of lichen amyloidosis associated with atopic dermatitis successfully treated with dupilumab: A case report and literature review.

Dermatologic therapy
2022

Multiple endocrine neoplasia type 2: A review.

Seminars in cancer biology
2021

Fractional Erbium-Doped Yttrium Aluminum Garnet Laser in the Treatment of Primary Cutaneous Amyloidosis.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2021

Successful Treatment of Lichen Amyloidosis Using a Fixed Combination of Halobetasol-Propionate and Tazarotene Lotion.

Journal of drugs in dermatology : JDD
2021

Dermatoscopic features of lichen amyloidosis: A case report.

The Australasian journal of dermatology
2020

Clinical resolution of generalized lichen amyloidosis with dupilumab: a new alternative therapy.

Dermatology online journal
2021

Treatment of lichen amyloidosis with fractional CO2 laser and topical steroid: a preliminary study of 10 cases.

Lasers in medical science
2020

A case report and differential diagnosis of pruritic pretibial skin lesions.

Acta dermatovenerologica Alpina, Pannonica, et Adriatica
2020

Multiple endocrine neoplasia type 2A with cutaneous lichen amyloidosis.

BMJ case reports
2019

A primer on the genetics of medullary thyroid cancer.

Current oncology (Toronto, Ont.)
2019

A Rare Presentation of Nodular Amyloidosis on the Lower Back.

Cureus
2019

Symmetric lichen amyloidosis: an atypical location on the bilateral extensor surfaces of the arms.

Cutis
2019

Postherpetic hypohidrosis-related isotopic response associated with lichen planus and lichen amyloidosis.

European journal of dermatology : EJD
2019

Clinicopathological Study of Primary Cutaneous Amyloidosis in a Tertiary Care Center of Eastern India Reveals Insignificant Association with Friction, Scrubbing, and Photo-Exposure: How valid is the "Keratinocyte Hypothesis"?

Indian journal of dermatology
2019

Long-term follow-up of RET Y791F carriers in Denmark 1994-2017: A National Cohort Study.

Journal of surgical oncology
2018

Image Gallery: Dermoscopy of lichen amyloidosis.

The British journal of dermatology
2018

The RET C611Y mutation causes MEN 2A and associated cutaneous.

Endocrine connections
2019

Successful Treatment of Lichen Amyloidosis With Trichloroacetic Acid Peels.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
2018

An intensely pruritic pebbled presentation.

Dermatology online journal
2018

Metastatic pheochromocytoma in MEN 2A: A rare association.

BMJ case reports
2017

Lichen amyloidosis of the scalp and forehead.

Dermatology online journal
2018

The Clinical Spectrum of Multiple Endocrine Neoplasia Type 2A with Cutaneous Lichen Amyloidosis in Ethnic Han Chinese.

Cancer investigation
2019

Lichen amyloidosis successfully treated with fractional ablative laser CO2: A new alternative therapeutic.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
2017

Dermatologic manifestations of endocrine disorders.

Translational pediatrics
2017

Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study.

Journal of clinical and diagnostic research : JCDR
2017

Alitretinoin treatment of lichen amyloidosis.

Dermatologic therapy
2017

Lichen amyloidosis involving the scalp.

The Australasian journal of dermatology
2017

Successful treatment of lichen amyloidosis accompanied by atopic dermatitis by fractional CO2 laser.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
2017

Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review.

American journal of clinical dermatology
2017

Increase in sensory sensitivity around, but not in the central part of, the hyperkeratotic papule in lichen amyloidosis.

The British journal of dermatology
2017

Lichen amyloidosis associated with rheumatoid arthritis: unique presentation in a Bulgarian patient.

Sao Paulo medical journal = Revista paulista de medicina
2016

Image Gallery: Lichen amyloidosis on the external auditory canal.

The British journal of dermatology
2016

Generation of an induced pluripotent stem cell line from a patient with hereditary multiple endocrine neoplasia 2A (MEN2A) syndrome with RET mutation.

Stem cell research
2017

Ripple-pattern lichen amyloidosis in a case of ichthyosis vulgaris with a novel FLG mutation.

Journal of the European Academy of Dermatology and Venereology : JEADV
2016

[Genotype-phenotype correlations in multiple endocrine neoplasia type 2].

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
2016

Oral isotretinoin: A new treatment alternative for generalized lichen amyloidosis.

The Australasian journal of dermatology
2016

Treatment of primary cutaneous amyloidosis with laser: a review of the literature.

Lasers in medical science
2016

MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Familial cancer
2016

Cutaneous lichen amyloidosis in multiple endocrine neoplasia.

Internal medicine journal
2015

THE AUTOIMMUNE CONSTELLATION IN LICHEN AMYLOIDOSIS.

Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi
2015

Vesicular lesions in lichen amyloidosis.

Indian journal of dermatology, venereology and leprology
2015

Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
2016

Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.

World journal of surgery
2015

Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: A randomized clinical trial.

Lasers in surgery and medicine
2016

Successful treatment of lichen amyloidosis using capsaicin 8% patch.

Journal of the European Academy of Dermatology and Venereology : JEADV
2015

Fractional 1,550 nm Ytterbium/Erbium fiber laser in the treatment of lichen amyloidosis: clinical and histological study.

Lasers in surgery and medicine
2015

Bullous variant of familial biphasic lichen amyloidosis: a unique combination of three rare presentations.

Indian journal of dermatology
2015

Epidermolysis bullosa pruriginosa: a case with a novel mutation and co-existent lichen amyloidosus.

Indian journal of dermatology, venereology and leprology
Ver todos os 163 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Líquen amiloidótico.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Líquen amiloidótico

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Dermatologic Features of Endocrine Tumor Syndromes-Systematic Review and Meta-Analysis.
    International journal of dermatology· 2026· PMID 41165034mais citado
  2. Genotype-phenotype correlations of germline mutations in exon 10 of the RET proto-oncogene from 14 MEN2A families of Ethnic Han Chinese.
    PloS one· 2025· PMID 40934230mais citado
  3. An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.
    Nature communications· 2025· PMID 40456762mais citado
  4. Refractory Lichen Amyloidosis Coexisting With Atopic Dermatitis Responsive to Sequential Janus Kinase Inhibitor Therapy: Upadacitinib Followed by Abrocitinib.
    The Kaohsiung journal of medical sciences· 2025· PMID 41316943mais citado
  5. Landscape of Phenotype-Genotype Correlations in Romanian Patients with Medullary Thyroid Carcinoma.
    Cancers· 2025· PMID 41514606mais citado
  6. Nemolizumab for Lichen Amyloidosis With Serial Serum Interleukin-31 Levels: A Case Report.
    J Dermatol· 2026· PMID 41964247recente
  7. Improvement of Low-Dose Abrocitinib-Resistant Lichen Amyloidosis with Dupilumab: Two Case Reports.
    Clin Cosmet Investig Dermatol· 2025· PMID 41287646recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:49804(Orphanet)
  2. MONDO:0018856(MONDO)
  3. GARD:18839(GARD (NIH))
  4. Busca completa no PubMed(PubMed)
  5. Q55788384(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Líquen amiloidótico
Compêndio · Raras BR

Líquen amiloidótico

ORPHA:49804 · MONDO:0018856
CID-10
E85.4+ · Amiloidose
CID-11
Início
Adolescent, Adult
MedGen
UMLS
C5779561
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades